Report of Foreign Issuer (6-k)
September 11 2017 - 8:02AM
Edgar (US Regulatory)
UNITED
STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
REPORT
OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE
13a-16
or 15d-16
UNDER
THE SECURITIES EXCHANGE ACT
of 1934
For
the Month of September 2017
001-37521
(Commission
File Number)
INTEC
PHARMA LTD.
(Translation
of registrant’s name into English)
12
Hartom Street
Har Hotzvim, Jerusalem 9777512, Israel
(+972)
(2) 586-4657
(Address
of principal executive office)
Indicate
by check mark whether the registrant files or will file annual reports under cover
Form
20-F or Form 40-F.
Form
20-F ☒ Form 40-F ☐
Indicate
by check mark if the registrant is submitting the Form 6-K in paper as permitted by
Regulation S-T Rule 101(b)(l): _________
Indicate
by check mark if the registrant is submitting the Form 6-K in paper as permitted by
Regulation S-T Rule 101(b)(7): _________
EXPLANATORY
NOTE
On
September 8, 2017, Intec Pharma Ltd., issued a press release titled “Intec Pharma to Participate in the 19th Annual Rodman
& Renshaw Global Investment Conference.”
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf
by the undersigned, thereunto duly authorized.
|
INTEC
PHARMA LTD.
|
|
|
|
|
By:
|
/s/
Nir
Sassi
|
|
|
Name:
Nir Sassi
|
|
|
Title:
Chief Financial Officer
|
|
|
|
Date:
September 11, 2017
|
|
|
EXHIBIT
INDEX
Intec Parent (NASDAQ:NTEC)
Historical Stock Chart
From Aug 2024 to Sep 2024
Intec Parent (NASDAQ:NTEC)
Historical Stock Chart
From Sep 2023 to Sep 2024